FAQs

Cognition’s executive team is based in Purchase, NY. The company is headquartered in Pittsburgh, PA, where the firm’s R&D laboratories are located

Cognition is incorporated in Delaware.

Cognition’s IPO was in October 8, 2021. The announcement of the pricing of its initial public offering may be found here.

Cognition’s IPO priced at $12.00 on the Nasdaq Global Market.

Cognition’s fiscal year concludes on December 31st.

The transfer agent and registrar of our common stock is American Stock Transfer and Trust Company LLC.

For questions about your stock please contact our transfer agent, American Stock Transfer and Trust Company LLC. Their address is: 6201 15th Avenue in Brooklyn, NY 11219. You may also reach them by phone at (800) 937-5449.

To make changes on your shareholder account please contact our transfer agent, American Stock Transfer and Trust Company LLC. Their address is: 6201 15th Avenue in Brooklyn, NY 11219. You may also reach them by phone at (800) 937-5449.

Ernst & Young, LLP is Cognition’s auditor.

Goodwin Procter is Cognition’s legal counsel.
 
Sign up for email alerts below or email info@cogrx.com to be placed on the company’s email distribution list.
 
A list of SEC filings, including our annual report on form 10K can be found here, as well as other information may be found on the Financial Information page of this website here.
 
A list of covering analysts as well as other market information may be found here
 

Investor Relations Contact

Cognition Therapeutics
info@cogrx.com

Mikey Moyer
LifeSci Advisors
mmoyer@lifesciadvisors.com

Email Alerts

Scroll to Top

Thank you for your interest in Cognition’s publications. A PDF of the poster you are interested in will be made available in accordance with the congress’ embargo policy. Please check back soon. 

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.